Overview Fundamentals API Earnings EOD API Sample Code Pricing

Ovid Therapeutics Inc (OVID NASDAQ) stock market data APIs

$0.97 -0.05(-4.9%) as of July 19, 2024
Price chart is built with Anychart

Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. The company is developing soticlestat, a novel cholesterol 24 hydroxylase inhibitor, which is in Phase 3 clinical trials for the potential treatment of patients with resistant epilepsies; OV329, a GABA aminotransferase inhibitor which is in Phase 1 clinical trials for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule direct activator of the KCC2 transporter, which is in Phase 1 clinical trials for treating epilepsies. It also develops OV815, that focuses on the mutations associated with KIF1A-associated neurological disorder (KAND); OV888 (GV101), a highly selective rock2 inhibitor which is in Phase 1 double-blind multiple-ascending dose trial; OV825, has advanced to potential candidate lead identification for the rare neurodevelopmental condition HNRNPH2 (Bain Syndrome); and OV882, a short hairpin RNA gene therapy for the treatment of Angelman syndrome. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.

Ovid Therapeutics Inc Financial Data Overview

1.02
0.97
-
1.03
0.9608
0.68-4.1389
72 363 K
70 945 K
474 K
-0.17
0.435
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'OVID',
Type: 'Common Stock',
Name: 'Ovid Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG009F0TD76',
ISIN: NULL,
CUSIP: NULL,
CIK: '1636651',
EmployerIdNumber: '46-5270895',
FiscalYearEnd: 'December',
IPODate: '2017-05-05',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Ovid Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 474 K
  • EBITDA -61 246 180
  • Earnings Per Share -0.72
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Ovid Therapeutics Inc Earnings via APIs

  • Latest Release 2024-05-14
  • EPS/Forecast -0.22

Get Ovid Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com